🇬🇧 Enhertu in United Kingdom

Enhertu (trastuzumab-deruxtecan) regulatory status in United Kingdom.

Marketing authorisations

MHRA

  • Status: likely_approved

MHRA

  • Status: likely_approved

Enhertu in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United Kingdom

Frequently asked questions

Is Enhertu approved in United Kingdom?

Yes. MHRA has authorised it; MHRA has authorised it.

Who is the marketing authorisation holder for Enhertu in United Kingdom?

Daiichi Sankyo is the originator. The local marketing authorisation holder may differ — check the official source linked above.